Rick van Rijn

28PUBLICATIONS
105CO-AUTHORS
Infant and child healthPredictive and prognostic markersMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Dec 11, 2025
Why is the International Pediatric Radiology Congress important for the health and well-being of the subspecialty of pediatric radiology?

Michael J Callahan, Rick R van Rijn

|Oct 16, 2025
Childhood, Adolescent and Young Adult Poor-Prognosis Rhabdomyosarcoma.

Ajla T Wasti, Gianni Bisogno, Raquel Hladun

|Oct 10, 2025
Can Whole-Body Diffusion-weighted MRI Become a One-Stop-Shop Imaging Modality in Pediatric Sarcoma Imaging?

Rick R van Rijn, Rutger A J Nievelstein

|Mar 07, 2025
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European <i>Paediatric</i> Soft Tissue Sarcoma Study Group RMS 2005 Trial.

Gianni Bisogno, Julia Chisholm, Raquel Hladun

|Oct 16, 2024
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). <i>Cancers</i> 2024, <i>16</i>, 998.

Julia Chisholm, Henry Mandeville, Madeleine Adams

|Mar 13, 2024
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

Julia Chisholm, Henry Mandeville, Madeleine Adams

Pageof 5

Frequent Collaborators

10 joint publications

Johannes H M Merks

8 joint publications

Gianni Bisogno

6 joint publications

Julia Chisholm

6 joint publications

Michela Casanova